103 related articles for article (PubMed ID: 28865104)
21. [Expression of cytochrome P450 related genes in oral submucous fibrosis tissue].
Xie H; Liu J; Ling TY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Dec; 47(12):743-7. PubMed ID: 23328101
[TBL] [Abstract][Full Text] [Related]
22. Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study.
Thubashini M; Malathi N; Kannan L
Indian J Dent Res; 2011; 22(2):256-9. PubMed ID: 21891896
[TBL] [Abstract][Full Text] [Related]
23. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
[TBL] [Abstract][Full Text] [Related]
24. Oral submucous fibrosis-an increasing global healthcare problem.
Brennan PA; Arakeri G
J Oral Pathol Med; 2017 Jul; 46(6):405. PubMed ID: 28672092
[No Abstract] [Full Text] [Related]
25. [Oral submucous fibrosis in a 31-year-old Indian women: first case report from Germany].
Reichart PA; Philipsen HP
Mund Kiefer Gesichtschir; 2006 May; 10(3):192-6. PubMed ID: 16568335
[TBL] [Abstract][Full Text] [Related]
26. [A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis].
Guo F; Jian XC; Zhou SH; Li N; Hu YJ; Tang ZG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):494-7. PubMed ID: 22169748
[TBL] [Abstract][Full Text] [Related]
27. Salivary coagulopathy and humoral response in oral submucous fibrosis (OSMF).
Chatuvedi VN; Sharma AK; Chakrabarati S
J Indian Dent Assoc; 1991 Mar; 62(3):51-3, 59. PubMed ID: 1820393
[No Abstract] [Full Text] [Related]
28. Estimation of copper in saliva and areca nut products and its correlation with histological grades of oral submucous fibrosis.
Mohammed F; Manohar V; Jose M; Thapasum AF; Mohamed S; Shamaz BH; D'Souza N
J Oral Pathol Med; 2015 Mar; 44(3):208-13. PubMed ID: 25047540
[TBL] [Abstract][Full Text] [Related]
29. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
[TBL] [Abstract][Full Text] [Related]
30. Clinical and functional staging of oral submucous fibrosis.
Haider SM; Merchant AT; Fikree FF; Rahbar MH
Br J Oral Maxillofac Surg; 2000 Feb; 38(1):12-5. PubMed ID: 10783440
[TBL] [Abstract][Full Text] [Related]
31. [Collagen content and types in oral submucous fibrosis].
Huang IY; Shieh TY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Mar; 5(3):162-71. PubMed ID: 2733074
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China.
Liu B; Shen M; Xiong J; Yuan Y; Wu X; Gao X; Xu J; Guo F; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):337-45. PubMed ID: 26130067
[TBL] [Abstract][Full Text] [Related]
33. Periodontal findings in patients with oral submucous fibrosis and comet assay of affected gingival epithelial cells.
Dodani K; Anumala N; Avula H; Reddy K; Varre S; Kalakonda BB; Arora N; Suri C; Avula JK
J Periodontol; 2012 Aug; 83(8):1038-47. PubMed ID: 22166165
[TBL] [Abstract][Full Text] [Related]
34. [Periodontal status in patients with oral submucous fibrosis].
Xu C; Zhao J; Li Q; Li F; Li J; Zhang L; Guo F; Gao Q; Wu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 34(9):914-8. PubMed ID: 19779267
[TBL] [Abstract][Full Text] [Related]
35. PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix.
Wang J; You J; Wang L; Wang H; Tian T; Wang W; Jia L; Jiang C
Oncotarget; 2017 Sep; 8(43):74806-74819. PubMed ID: 29088825
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a questionnaire to evaluate association of tobacco abuse with oral submucous fibrosis.
Mehrotra D; Agarwal GG; Kumar S; Shukla A; Asthana A
Asia Pac J Public Health; 2015 Mar; 27(2):NP132-42. PubMed ID: 22194626
[TBL] [Abstract][Full Text] [Related]
37. Oral submucous fibrosis in India: a new epidemic?
Gupta PC; Sinor PN; Bhonsle RB; Pawar VS; Mehta HC
Natl Med J India; 1998; 11(3):113-6. PubMed ID: 9707699
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of clinicofunctional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy.
Ceena DE; Bastian TS; Ashok L; Annigeri RG
Indian J Dent Res; 2009; 20(3):271-6. PubMed ID: 19884707
[TBL] [Abstract][Full Text] [Related]
39. Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: a preliminary clinical trial in a Chinese cohort.
Jiang X; Zhang Y; Li F; Zhu Y; Chen Y; Yang S; Sun G
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1540-6. PubMed ID: 26165773
[TBL] [Abstract][Full Text] [Related]
40. TFM classification and staging of oral submucous fibrosis: A new proposal.
Arakeri G; Brennan PA
J Oral Pathol Med; 2018 May; 47(5):539. PubMed ID: 29473974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
